Galectin Therapeutics
GALT
GALT
83 hedge funds and large institutions have $20.6M invested in Galectin Therapeutics in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 21 closing their positions.
Holders
83
Holders Change
-9
Holders Change %
-9.78%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
23
Reduced
20
Closed
21
Calls
$242K
Puts
$943K
Net Calls
-$701K
Net Calls Change
+$1.11M
Top Buyers
| 1 |
1
Jane Street
New York
|
$1.58M |
| 2 |
2
LPL Financial
San Diego,
California
|
$774K |
| 3 |
3
Millennium Management
New York
|
$305K |
| 4 |
VCM
4
Vivaldi Capital Management
Chicago,
Illinois
|
$364K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$354K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FIA
101
FNY Investment Advisers
New York
| – | – | -600 | Closed |
|
|
AW
102
Avion Wealth
The Woodlands,
Texas
| – | – | -237 | Closed |
|
|
SCM
103
Sterling Capital Management
Charlotte,
North Carolina
| – | – | -74 | Closed |
|
104
Legal & General Group
London,
United Kingdom
| – | – | -38 | Closed |
|
105
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
AAA
106
Affinity Asset Advisors
New York
| – | – | – | – |
|